4
Changes in Ownership
GYRE THERAPEUTICS, INC. Filed Acc 0001140361-25-001059
President sold 1,113 shares at an average $10.02 ($11,157)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ma Songjiang President | 2025-01-10 | Sale 10b5-1 | −1,057 | $10.02 | $10,591 | 2,915,194 | I |
| Ma Songjiang President | 2025-01-13 | Sale 10b5-1 | −56 | $10.10 | $566 | 2,915,138 | I |
| Open-market sales · 1,113 sh · avg $10.02 · $11,157 | |||||||
Loading xslF345X05/form4.xml…